Glufosfamide

CAS No. 132682-98-5

Glufosfamide ( D-19575;D19575 )

Catalog No. M11306 CAS No. 132682-98-5

A conjugate of glucose and active alkylating moiety of ifosfamide with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 239 Get Quote
50MG 1251 Get Quote
100MG 1971 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Glufosfamide
  • Note
    Research use only, not for human use.
  • Brief Description
    A conjugate of glucose and active alkylating moiety of ifosfamide with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters.
  • Description
    A conjugate of glucose and active alkylating moiety of ifosfamide with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters; has the better cell permeability than ifosfamide; Glufosfamide utilizes the normal cell glucose transport mechanism (SAAT1) for transport into the cell, enhances the activity of gemcitabine in vitro and in vivo.Pancreatic Cancer Phase 3 Clinical
  • Synonyms
    D-19575;D19575
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA Alkylator
  • Recptor
    DNA Alkylator
  • Research Area
    Cancer
  • Indication
    Pancreatic Cancer

Chemical Information

  • CAS Number
    132682-98-5
  • Formula Weight
    383.16
  • Molecular Formula
    C10H21Cl2N2O7P
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=P(NCCCl)(NCCCl)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O
  • Chemical Name
    N,N'-Bis(2-chloroethyl)phosphorodiamidic acid beta-D-glucopyranosyl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Veyhl M, et al. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2914-9.
2. Styczynski J, et al. Anticancer Res. 2002 Jan-Feb;22(1A):247-50.
3. Seker H, et al. Br J Cancer. 2000 Feb;82(3):629-34.
4. Ammons WS, et al. Neoplasia. 2007 Aug;9(8):625-33.
molnova catalog
related products
  • Alchemix

    A dual action as an alkylating agent and topoisomerase inhibitor with potent activity against anthracycline- and cisplatin-resistant tumor cancer.

  • Temozolomide

    An alkylating agent used as a treatment of some brain cancers, astrocytoma and glioblastoma.

  • Thio-TEPA

    An alkylating agent used to treat cancer that has been previously used in the palliation of a wide variety of neoplastic diseases.